No black box warning on record for Calquence

As of the latest FDA labeling reviewed, Calquence (ACALABRUTINIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Calquence medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious and Opportunistic Infections: Monitor for signs and symptoms of infection and treat promptly. ( 5.1 ) • Hemorrhage: Monitor for bleeding and manage appropriately. ( 5.2 ) • Cytopenias: Monitor complete blood counts regularly. ( 5.3 ) • Second Primary Malignancies: Other malignancies have occurred, including skin cancers and other solid tumors. Advise patients t

No black box warning on record for Calquence

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious and Opportunistic Infections: Monitor for signs and symptoms of infection and treat promptly. ( 5.1 ) • Hemorrhage: Monitor for bleeding and manage appropriately. ( 5.2 ) • Cytopenias: Monitor complete blood counts regularly. ( 5.3 ) • Second Primary Malignancies: Other malignancies have occurred, including skin cancers and other solid tumors. Advise patients t

Calquence Black Box Warning

No black box warning on record for Calquence

Other warnings & precautions

Calquence Black Box Warning

No black box warning on record for Calquence

Other warnings & precautions